Anti-convulsant treatment benefits disruptive, explosive youth

Children and adolescents with certain severe disruptive behavior disorders that are marked by explosive temper caused by irritable mood swings demonstrated significant behavior improvement when treated with the anti-convulsant divalproex (Depakote), according to a preliminary study briefly reported in the May issue of the American Journal of Psychiatry.

In the joint New York State Psychiatric Institute, Columbia University study of twenty outpatients ages 10 to 18 who met specific criteria for explosive temper and mood variations, researchers found that 80% or more of those receiving the medication responded positively and with improved behavior and responses. "These are kids who cannot control their behavior, who get placed in special education classes from an early age, who don't get exposed to normal kids their own age, and who are deprived of normal socialization experiences," said lead researcher Stephen J. Donovan, M.D.

"Since children and adolescents with disruptive disorders are at high risk for delinquency and addiction, identifying a subgroup that can be helped with medications as part of their comprehensive psychosocial treatment, could have major public health implications," Dr. Donovan added. "Explosive behavior among a small number of children and youth is a significant problem in our schools and communities and deserves further research. This study suggests that a particular type of disruptive behavior -- characterized by explosive temper driven by irritable mood -- may have a biological component that responds positively to anti-convulsant medications." Dr. Donovan said the double-blind placebo-controlled crossover study did not evaluate use of the medication in other forms of disruptive behavior, and did not examine the long term consequences of its use.

Herbert Sacks, M.D., noted Yale child and adolescent psychiatrist and a past President of the APA, cautioned that the study, while promising, is preliminary. He noted t

Contact: Cecilia Obejero
American Psychiatric Association

Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
4. New treatment for fibromyalgia
5. The impact of genetic variations on the treatment of early rheumatoid arthritis
6. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
7. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
8. Colleagues to recognize research leadership in cancer detection, prevention and treatment
9. New view of leukemia cells identifies best treatment options, Stanford researchers say
10. Genetic model for devastating form of paraplegia suggests new treatments
11. Protective mechanism exploited by tumors may provide new cancer treatment

Post Your Comments:

(Date:10/4/2017)...  GCE Solutions, a global clinical research organization (CRO), announces the ... on October 4, 2017. Shadow is designed to assist medical writers ... 0070 of the European Medicines Agency (EMA) in meeting the requirements ... ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology:
Cached News: